feed,title,long_url,short_url
Benzinga,Longeveron Spikes As Lead Drug Produces Dose-Dependent Response In Aging Frailty Study; Primary Endpoint Not Met,https://benzinga.com/general/biotech/21/08/22483266/longeveron-spikes-as-lead-drug-produces-dose-dependent-response-in-aging-frailty-study-primary-en,https://j.mp/3AGnKPm
